Frequently Asked Questions
Global Apheresis Market was Valued at USD 2.20 Billion in 2021 and is Expected to Reach USD 4.01 Billion by 2029.
Global Apheresis Market is Expected to Witness CAGR of 8.95% During the Forecast Period of 2022-2029
The surge in demand for demand for source plasma, increase in the demand for blood components and presence of favourable reimbursement are the major drivers expected to drive the growth of the Apheresis Market.
Some of the major players operating in the Apheresis Market are Fresenius Kabi AG (Germany), Kidde-Fenwal Inc. (US), Haemonetics Corporation (US), Isto Biologics (US), Asahi Kasei Medical Co. Ltd. (Japan), TERUMO BCT, INC (US), Otsuka Holdings Co., Ltd. (Japan), among others.
The Countries Covered in the Apheresis Market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
